Absolute Contraindications; Relative Contraindications - Game ready ATX C-T SPINE Guia Del Usuario

Ocultar thumbs Ver también para ATX C-T SPINE:
Tabla de contenido

Publicidad

Idiomas disponibles
  • ES

Idiomas disponibles

  • ESPAÑOL, página 65
C-T SPINE WRAP APPLICATION
Slide one arm through the Wrap.
1
Take hold of the shoulder wings (A) and
3
pull the Wrap down gently to ensure
good contact with the back of the neck.
Adjust the two side straps (B & C)
5
equally on both sides of the body.
Elastic extension bands (E) on each side of the
chest straps allow the Wrap to accommodate
various body sizes. Unfasten the side straps;
detach the elastic strap on the inside and
reattach the loop towards the back of the Wrap.
Repeat for the other side.
Slide the other arm through the other
2
side of Wrap.
Fasten the hook and loop closure at the
4
center of the chest.
Adjust the two shoulder straps (A & C)
6
by completely unhooking and reapplying
them over the chest and shoulders – Take care
to keep Connector (F) unobstructed.
Attach the Wrap to the Control Unit with
7
the Connector Hose. There should be an
audible "click" . To disconnect, simply press the
blue or gray button and remove the connector
from the Wrap.
FOR USE WITH
GAME READY GRPRO 2.1 SYSTEM

ABSOLUTE CONTRAINDICATIONS

Therapy in these situations should not be used
in patients.
Compression Therapy using the Game Ready
GRPro 2.1 System or any compression therapy
device should not be used in patients:
• Who are in the acute stages of inflammatory phlebitis in the affected region.
• Who have any current clinical signs suggestive of deep vein thrombosis in the
affected region.
• Who have significant arteriosclerosis or other vascular ischemic disease in the
affected region.
• Who have any significant risk factors or current clinical signs of embolism (e.g.
pulmonary embolus, cerebral infarction, atrial fibrillation, endocarditis, myocardial
infarction, or atheromatous embolic plaque).
• Who have a condition in which increased venous or lymphatic return is not desired
in the affected extremity (e.g., carcinoma).
• Who have decompensated hypertonia in the affected region.
Cryotherapy using the Game Ready GRPro 2.1 System or any cryotherapy
device should not be used in patients:
• Who have significant vascular impairment in the affected region (e.g., from prior
frostbite, diabetes, arteriosclerosis or ischemia).
• Who have known hematological dyscrasias which affect thrombosis (e.g.,
paroxysmal cold hemoglobinuria, cryoglobulinemia, sickle-cell disease, serum cold
agglutinins).

RELATIVE CONTRAINDICATIONS

Therapy for these conditions should be used in patients only under the
supervision of a licensed healthcare practitioner.
Compression Therapy with the Game Ready GRPro 2.1 System should be
used only under the supervision of a licensed healthcare practitioner in
patients:
• Who have an open wound in the affected region (the wound must be dressed
prior to use of Game Ready).
• Who have an acute, unstable (untreated) fracture in the affected region.
• Who are children under 18 years old or patients who have cognitive disabilities or
communication barriers, whether temporary (due to medication) or permanent.
• Who have a cardiac insufficiency or congestive heart failure (with associated
edema in the extremities or lungs).
• Who have a localized unstable skin condition (e.g., dermatitis, vein ligation,
gangrene, or recent skin graft).
• Who have erysipelas or other active infection in the affected region.
Cryotherapy with the Game Ready GRPro 2.1 System should be used
only under the supervision of a licensed healthcare practitioner in
patients:
• Who have Raynaud's disease or cold hypersensitivity (cold urticaria).
• Who have hypertension or extreme low blood pressure.
• Who have diabetes.
• Who have compromised local circulation or neurologic impairment (including
paralysis or localized compromise due to multiple surgical procedures) in the
affected region.
• Who have a localized unstable skin condition (e.g., dermatitis, vein ligation,
gangrene, or recent skin graft).
• Who have rheumatoid arthritis in the affected region.
• Who are children under 18 years old or patients who have cognitive disabilities or
communication barriers, whether temporary (due to medication) or permanent.

Publicidad

Tabla de contenido
loading

Este manual también es adecuado para:

590502

Tabla de contenido